As per our database, 62 hedge fund portfolios held Abbott Laboratories (NYSE:ABT) at the end of the third quarter, which was 61 in the previous quarter. We discussed Abbott Laboratories (NYSE:ABT) in another article and shared the list of dividend stocks that beat the market last five years. In addition, please check out our hedge fund investor letters Q4 2022 page for more investor letters from hedge funds and other leading investors. Suggested Articles: Disclosure: None. This article is originally published at Insider Monkey.